Academic Journal
Q1Vaccine
About Vaccine
Vaccine is a scholarly journal published by Elsevier Ltd. SCImago 2025 places it in Q1 with an SJR of 1.186 and an H-index of 230.
Its listed coverage is 1983-2026 and its research categories include Immunology and Microbiology (miscellaneous) (Q1); Infectious Diseases (Q1); Public Health, Environmental and Occupational Health (Q1); Veterinary (miscellaneous) (Q1); Molecular Medicine (Q2). The 2025 dataset reports 1198 documents and 9838 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Vaccine Coverage and Hesitancy, Influenza Virus Research Studies, Respiratory viral infections research, Viral gastroenteritis research and epidemiology, Pneumonia and Respiratory Infections, Bacterial Infections and Vaccines.
Recent Research Articles
Latest publications matched automatically by ISSN.
Measles outbreak risk in Afghanistan: provincial immunity gaps and epidemic potential following immunisation system disruption
Rajeev Ranjan, Palwasha Anwari, Abigail Colson, Robert van der Meer et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129078Cell culture-derived vaccine for rabbit haemorrhagic disease virus 2
Elena Smertina, Madi Rutherford, Megan Pavy, Nina Huang et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129067Scaling up vaccination for people living in prisons: a global person-centred need for public health
Esergita Thanasi, Joseph McGregor-Harper, Maria Paola Tramonti Fantozzi, Nicola Cocco et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129039A recombinant attenuated PRRSV vaccine expressing the PCV2 capsid protein confers protective immunity in pigs
Shuo-Lei Gao, Jie-Cong Yan, Juan Wang, Qing-Yan Liu et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129106Real-world effectiveness of the influenza vaccine among school-aged children in Shenzhen, China, 2024–2025 season: A test-negative design study
Jianhua Lu, Zhiyao Ouyang, Fang Huang, Xu Xie et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129100Knowledge as a predictor of parental vaccine hesitancy during children's first year of life
Malena Gonçalves Almeida, Beatriz Fátima Alves de Oliveira, Eugênio Barbosa de Melo Júnior, Ana Raisla de Araújo Rodrigues et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129127A cohort study to assess the safety and coverage of COVID-19, influenza, and pertussis vaccine in Australian pregnant women
Hassen Mohammed, Prabha Andraweera, Helen S. Marshall
2026-10 · DOI: 10.1016/j.vaccine.2026.129081Coverage and adherence to the German childhood vaccination schedule: results from the KUNO-Kids health study
Margarida Arede, Susanne Brandstetter, Andreas Beyerlein, Michael Kabesch et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129164Secretory expression of tetrameric neuraminidase enhanced by signal peptide optimization elicits robust immunity against influenza infection in mice
Lisha Deng, Xianmiao Ye, Xin Chen, Xinru Hu et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129118Determinants associated with lower HPV vaccination uptake in the school-based program for girls – A follow-up of the Swedish National Immunization Program, 2013–2023
Emma Appelqvist, Emma Löf, Sharon Kühlmann-Berenzon, Alexander Ploner et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129083Vaccine- and infection-induced pneumococcal and DENV-NS1 antibodies reveal differential transplacental transfer and maternal–infant early exposure burden
Daniela Polanía-Espinosa, Doris Salgado, Rocío Vega, Diana Castañeda-Uvajoa et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129138Systematic review of the mutations in the active antigenic site Ø of the prefusion F protein of the Respiratory Syncytial Virus (RSV) following the implementation of monoclonal antibody prophylaxis
Maria M. Berikopoulou, Elizabeth-Barbara Tatsi, Tania Siahanidou, Athanasios Michos et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129069Ethical considerations of incentive structures in vaccine acceptance research
Mohamed Amer Musrati, Salem Shenaisheh, Mohamed A. Elemraid
2026-10 · DOI: 10.1016/j.vaccine.2026.129102Preclinical toxicity and immunogenicity of a quadrivalent recombinant influenza hemagglutinin vaccine (SCVC101) in rhesus monkeys
Jianmin Guo, Cailing Dai, Yuankeng Huang, Jinlong Dai et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129137Digital twins and explainable AI across the vaccine life cycle: from mRNA manufacturing to thermostability, cold-chain logistics, and immunisation services
Okechukwu Paul-Chima Ugwu, Michael Ben Okon, Fabian C. Ogenyi, Jovita Nnenna Ugwu et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129131Immunogenicity of norovirus VP1-expressing silkworm (Bombyx mori) pupae as an edible vaccine candidate
Tomoki Sasaki, Akitsu Masuda, Jae Man Lee, Shigeyuki Tamiya et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129108Erratum to “Vaccine effectiveness of mRNA-1345 against RSV-associated hospitalization and medically attended acute respiratory illness among US veterans, 2025–2026” [Vaccine 88 (2026) 128882]
Kevin W. McConeghy, Elissa H. Wilker, Frank DeVone, Benjamin Skov et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129072Wuhan-ancestral multi-antigen SARS-CoV-2 virus-like particles protect against the omicron sublineage JN.1 variant
Seung-Ji Kim, Ho-Won Kim, Seung-Eun Son, Jin-Ha Song et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129059Mandates or “Medical Freedom”? What Florida parents' attitudes suggest about the future of childhood vaccination
Amelia M. Jamison, Samee Saiyed, Lauren M. Gardner
2026-10 · DOI: 10.1016/j.vaccine.2026.129060Safety first, science second: Healthcare workers' conditional trust and willingness to participate in Lassa fever vaccine trials in Nigeria
Zubairu Iliyasu, Muhammad Sani Abubakar, Bilkisu Z. Iliyasu, Nafisa S. Nass et al.
2026-10 · DOI: 10.1016/j.vaccine.2026.129162Reviews
Community Reviews
Version History
September 8, 2026 at 12:03 am
September 8, 2026